It is nevertheless noteworthy that an increase in β-galactosidase was observed at the protein level in tumors derived from the CMS4 transcriptomic subtype and the integrated phenotype corresponding to EMT as expected [57], although expression of the GLB1 transcript was increased in CRC samples. Here, GLB1 is linked to colorectal carcinoma.